Merck & Co. Inc. buy Citigroup Inc.
Start price
25.10.24
/
50%
€96.70
Target price
25.10.25
€120.32
Performance (%)
-21.92%
End price
26.10.25
€75.50
Summary
This prediction ended on 26.10.25 with a price of €75.50. The price of Merck & Co. Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.92%. Citigroup_Inc_ has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. Dividends of €1.58 are taken into consideration when calculating the performance. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 1.777% | 1.777% | -9.484% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by Citigroup_Inc_ for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Citigroup Inc. from $140.00 to $130.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€93.60
28.01.25
28.01.25
€119.86
28.01.26
28.01.26
-7.36%
18.12.25
18.12.25
